The present study demonstrated that coumarin derivative N6 exerted an effective activity against HTNV in vivo and in vitro, and AKT1 was possibly involved in the molecular mechanism of N6 in treating viral infection. The gene discussed is AKT1; the disease is viral infectious disease.